Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Pei K. Loh"'
Publikováno v:
Stroke Research and Treatment, Vol 2011 (2011)
Our knowledge about various inherited and acquired causes of thrombophilic disorders has increased significantly during the past decade. Technology for various diagnostic tests for these rare disorders has matched the rapid advances in our understand
Externí odkaz:
https://doaj.org/article/9e76e803542f42d28848418e2f997519
Autor:
Leonard L Yeo, Ben Wakerley, Liang Shen, Prakash R Paliwal, Aftab Ahmad, Kay W Ng, Pei K Loh, Raymond C Seet, N Venketasubramanian, Benjamin K Ong, Lily Y Wong, Hock L Teoh, Bernard P Chan, Vijay K Sharma
Publikováno v:
Stroke. 43
Background and Purpose: Intravenously administered tissue plasminogen activator (IV-TPA) is the only approved therapeutic agent for arterial recanalization in acute ischemic stroke (AIS). Wide variations in rates and timing of neurological recovery a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::432f93fc7289bfa0d33687b362cbe70c
https://doi.org/10.1161/str.43.suppl_1.a3290
https://doi.org/10.1161/str.43.suppl_1.a3290
Autor:
Leonard L Yeo, Prakash R Paliwal, Ben Wakerley, Liang Shen, Aftab Ahmad, Pei K Loh, Kay W Ng, Vincent F Chong, Benjamin K Ong, N Venketasubramanian, Arvind K Sinha, Hock L Teoh, Lily Y Wong, Girish Bathla, Bernard P Chan, Vijay K Sharma
Publikováno v:
Stroke. 43
Background- Early identification of reliable predictors of functional outcomes is important for planning rehabilitation strategies in patients with acute ischemic stroke (AIS). Hyperdense middle cerebral artery sign (HMCAS) on unenhanced computerized
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::607324d7e73e8952fde0ea5a223edbda
https://doi.org/10.1161/str.43.suppl_1.a3267
https://doi.org/10.1161/str.43.suppl_1.a3267
Autor:
Leonard L Yeo, Liang Shen, Ben Wakerley, Aftab Ahmad, Kay W Ng, Pei K Loh, Prakash R Paliwal, N Venketasubramanian, Benjamin K Ong, Lily Y Wong, Su Jie, Raymond C Seet, Hock L Teoh, Bernard P Chan, Vijay K Sharma
Publikováno v:
Stroke. 43
Background: Intravenously administered tissue plasminogen activator (IV-TPA) remains the only approved therapeutic agent for arterial recanalization in acute ischemic stroke (AIS). Wide variations in the rates and timing of neurological recovery are
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b4dab3aa6a044a3f510fa07d734015fc
https://doi.org/10.1161/str.43.suppl_1.a3275
https://doi.org/10.1161/str.43.suppl_1.a3275